307 related articles for article (PubMed ID: 9679693)
1. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia.
Kamaliah MD; Zainal D; Mokhtar N; Nazmi N
Int J Dermatol; 1998 Jul; 37(7):520-3. PubMed ID: 9679693
[TBL] [Abstract][Full Text] [Related]
2. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.
Forman R; Koren G; Shear NH
Drug Saf; 2002; 25(13):965-72. PubMed ID: 12381216
[TBL] [Abstract][Full Text] [Related]
3. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
[TBL] [Abstract][Full Text] [Related]
4. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
Su JR; Haber P; Ng CS; Marquez PL; Dores GM; Perez-Vilar S; Cano MV
Vaccine; 2020 Feb; 38(7):1746-1752. PubMed ID: 31870573
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.
Lam NS; Yang YH; Wang LC; Lin YT; Chiang BL
J Microbiol Immunol Infect; 2004 Dec; 37(6):366-70. PubMed ID: 15599469
[TBL] [Abstract][Full Text] [Related]
6. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
7. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
Hosaka H; Ohtoshi S; Nakada T; Iijima M
J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.
Moreau JF; Watson RS; Hartman ME; Linde-Zwirble WT; Ferris LK
Pediatr Dermatol; 2014; 31(2):163-8. PubMed ID: 23679157
[TBL] [Abstract][Full Text] [Related]
9. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and mortality among patients with severe muco-cutaneous drug reactions.
Crüger AM; Kaur-Knudsen D; Zachariae C; Rasmussen HB; Thomsen SF
Dan Med J; 2015 Aug; 62(8):A5122. PubMed ID: 26239591
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
Gleghorn KL; Voigt C; Kelly B
Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
14. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
[TBL] [Abstract][Full Text] [Related]
15. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
[TBL] [Abstract][Full Text] [Related]
16. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
[TBL] [Abstract][Full Text] [Related]
17. Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics.
Gubernot D; Menis M; Whitaker B
Vaccine; 2023 Nov; 41(47):6922-6929. PubMed ID: 37891051
[TBL] [Abstract][Full Text] [Related]
18. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
[TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany.
Schöpf E; Stühmer A; Rzany B; Victor N; Zentgraf R; Kapp JF
Arch Dermatol; 1991 Jun; 127(6):839-42. PubMed ID: 2036029
[TBL] [Abstract][Full Text] [Related]
20. Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus.
Torchia D; Romanelli P; Kerdel FA
J Am Acad Dermatol; 2012 Sep; 67(3):417-21. PubMed ID: 22101216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]